The challenge to UK drug policy

References

• Amato L, Davoli M, Perruci C, Ferri M, Faggiano F, Mattick R. An overview of systematic evidence reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment 2005; 28: 321–329
   PubMed Web of Science ®Google Scholar
• Bloor M, Neale J, McKeganey N. Persisting local variations in prevalence of hepatitis C virus among Scottish problem drug users: Results from an anonymous screening study. Drugs: Education, Prevention and Policy 2006; 13: 189–191
   Web of Science ®Google Scholar
• Bruneau J, Franco E, Lamothe F, Lachance N, Desy M, Soto J. High rates of HIV infection among injecting drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology 1997; 146(12)994–1002
   PubMed Web of Science ®Google Scholar
• Gruer L, Cameron J, Elliot L. Building a city wide network for exchanging needles and syringes. British Medical Journal 1993; 306: 1394–1397
   PubMed Web of Science ®Google Scholar
• Hall W, Degenhardt L. Cannabis use and psychosis: A review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry 2000; 43: 26–34
   Google Scholar
• Hall W, Solowji L. The adverse effects of cannabis. Lancet 1998; 352: 1611–1616
   PubMed Web of Science ®Google Scholar
• Hay G, Gannon M, MacDougal J, Millar T, Eastwood C, McKeganey N. Local and national estimates of the prevalence of opiate use and/or crack cocaine use (2004/05). Measuring different aspects of problem drug use: methodological developments, M Sigleton, R Murray, L Tinsley. Home Office online Report 16/06, 2007, (2007)
   Google Scholar
• Health Protection Agency. Shooting Up Infections Among Injecting Drug Users in the United Kingdom 2004. London Health Protection Agency. 2005
   Google Scholar
• Home Office. Updated drug strategy. The Home Office, London 2002
   Google Scholar
• House of Commons. Science and technology committee fifth report. Staionary Office, London 2006
   Google Scholar
• International Working Group. The report of the independent working group on drug consumption rooms. Joseph Rowntree Foundation, YorkUK 2006
   Google Scholar
• Lloyd C, Hunt N. Drug consumption rooms: An overdue extension to harm reduction policy in the UK. International Journal of Drug Policy 2007; 18: 5–9
   PubMed Web of Science ®Google Scholar
• McKeganey N. The lure and loss of harm reduction. Addiction Research and Theory 2006; 14: 557–588
   Web of Science ®Google Scholar
• Morgan O, Griffiths C, Tuson B, Rooney C, Majeed A, & Hickman M. Trends in deaths related to drug misuse England and Wales. Health Statistics Quarterly, Autumn 2006 2007, London: National Statistics 1993–2004.
   Google Scholar
• Moss A. Epidemiology and the politics of needle exchange. American Journal of Public Health 2000; 90(9)1385–1388
   PubMed Web of Science ®Google Scholar
• Nutt D, King L, Saulsbury W, Blakemore C. Development of a rational scale to assess the harms of drugs of potential misuse. Lancet 2007; 369: 1047–1053
   PubMed Web of Science ®Google Scholar
• Reuter P, & Stevens A. An analysis of UK drug policy: A monograph prepared for the UK Drug Policy Commission. UK Drug Comission Policy, London 2007
   Google Scholar
• Rey J, Sawer M, Raphael B, Patton G, Lynskey M. Mental health of teenagers who use cannabis: Results of an Australian survey. British Journal of Psychiatry 2002; 180: 216–221
   PubMed Web of Science ®Google Scholar
• Rey J, Tennant C. Editorial: Cannabis and mental health. British Medical Journal 2002; 325: 1183–1184
   PubMed Web of Science ®Google Scholar
• Royal Society of Arts. Drugs facts: The report of the RSA Commission on illegal drugs communities and public policy. RSA, London 2007
   Google Scholar
• Scottish Executive, Information and Statistics Division. (2005). How many people are receiving methadone hydrochloride mixture for opiate dependence in Scotland and what are the prescribing costs per person, (Available at: www.drugmisuse.isdscotland.org/publications/local/isd_methadone.pdf)
   Google Scholar
• Uchtenhagen A, Dobler-Mikola A, Gutzwiller F. Medical prescription of narcotics: Background and intermediate results of a Swiss national project. European Research Journal 1996; 2: 201–207
   Google Scholar
• Uchtenhagen A, Dobler-Mikola A, Steffen A. A programme for a medical prescription of narcotics. A synthesis of results. European Addiction Research 1997; 3: 160–163
   Web of Science ®Google Scholar
• Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blatter R, Pfeifer S. Prescription of narcotics for heroin addicts. Main results of Swiss national cohort study. Vol. 1: Medical prescription of narcotics. Karger, BaselSwitzerland 1999
   Google Scholar
• UK Government. Tackling drugs to build a better Britain: The governments 10-year strategy for tackling drugs misuse. Stationery Office, London 1998
   Google Scholar
• Van den Brink W, Hendriks V, Van Ree J. Medical co-prescription of heroin to chronic treatment resistant methadone patients in the Netherlands. Journal of Drug Issues 1999; 29: 587–608
   Web of Science ®Google Scholar
• Van den Brink W, Vincent M, Hendriks V, Blanken P, Huijsman I, Van Ree J. Medical co-prescription of heroin. Two randomized controlled trials. Central Committee on the Treatment of Heroin Addicts, UtrechtThe Netherlands 2002
   Google Scholar
• Vertefeuille J, Marx MA, Tun W, Huettner S, Strathdee SA, & Vlahov D. Decline in Self-Reported High Risk Injection-Related Behaviors Among HIV Seropositive Participants in the Baltimore Needle Exchange Program. AIDS and Behavior 2000; 4: 381–388
   Google Scholar
• Vlahov DJ, unge B, Brookmeyer R, Cohn S, Riley E, Amenian H, Beilenson P. Reductions in High Risk Drug Use Behaviours Amongst Participants in the Baltimore Needle Exchange Prgramme. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 1997; 16(5): 400–406
   Google Scholar
• Wodak A, & Cooney S. Effectiveness of sterile needle and syringe programmes in reducing HIV/AIDS among injecting drug users: Evidence for action. (Technical Papers). World Health Organization, Geneva, Switzerland 2004
   Google Scholar